스크랩/신문 기사 Merck to seek emergency authorization for oral Covid treatment after ‘compelling JNKIM 2021. 10. 1. 20:29 https://www.cnbc.com/2021/10/01/merck-to-seek-emergency-authorization-for-oral-covid-19-treatment.html Merck to seek emergency authorization for oral Covid treatment after ‘compelling results’ in trials Merck and Ridgeback Biotherapeutics will seek emergency authorization for their drug, which they say could have “a profound impact in controlling the pandemic.” www.cnbc.com